Center for Dialysis Innovation

Q&A: Nephrologists’ perspectives matter in wearable dialysis device design Insight from nephrologists and nephrology nurses on a wearable hemodialysis device will aid in refining its design, according to a presenter at the Innovations in Dialysis: Expediting Advances Symposium.In collaboration with the American Society for Nephrology and the American Nephrology Nurses Asso...

Did you hear that we won our 3rd KidneyX prize for the AKTIV concept!

AKTIV - UW Center for Dialysis Innovation prototype The University of Washington Center for Dialysis Innovation (CDI) is working to develop a portable kidney-dialysis device, as well as other technology-enhanc...

Winner A Pro-Regenerative Vascular Access Graft: Surmounting Challenges Inhibiting Progress A Pro-Regenerative Vascular Access Graft: Surmounting Challenges Inhibiting Progress

My peeps! This is so cool. “Bye, vascular scars from dialysis access!”

Winner A Pro-Regenerative Vascular Access Graft: Surmounting Challenges Inhibiting Progress A Pro-Regenerative Vascular Access Graft: Surmounting Challenges Inhibiting Progress

“Seattle is the Yankees of kidney research. The city’s history of success in kidney innovation gives me faith that more discoveries will happen here.” — Bill Peckham, on dialysis for 28 years

👏 2019 was a groundbreaking year for kidney research! We cheered on the Kidney Research Institute, our collaboration with UW Medicine, as they launched the kidney-on-a-chip into space! We also got good news from the Center for Dialysis Innovation, which we helped launch in 2017. Its AKTIV portable kidney won a national KidneyX prize as a promising new device concept.

We are honored to receive the National Patient Engagement & Advocacy “National Voice Award “ at the AAKP 50th Anniversary Awards Banquet. Thank you, AAKP.

Dr. Jonathan Himmelfarb () and Rachel Meyers (ASN) outside the White House after meeting with the Health Policy team. Discussed kidney disease, prevention of kidney disease progression and changes needed to promote dialysis alternatives and increase transplants rates.

Today CDI Co-Director Dr. Jonathan Himmelfarb met with the White House Health Policy team to discuss kidney disease, the prevention of kidney disease progression and the changes needed to promote dialysis alternatives and increase transplants rates. !

You Are Just Now Telling Us About This? African American Perspectives of Testing for Genetic Susceptibility to Kidney Disease Variants of the APOL1 gene, which encodes apo L1, confer increased risk for CKD, ESKD, and reduced cadaveric kidney transplant survival, and likely contribute to kidney disease disparities among African American individuals in the United States. To date, few studies have gathered African Americans

Invite your colleagues to attend IDEAS 2019